The newly announced 16-month reform roadmap of PhilHealth (or the Philippine Health Insurance Corp.) is a welcome sign of urgency. Developed with the Department of Health (DOH) and more than 100 representatives of development institutions, the academe, civil society and other sectors, the plan seeks to improve access, equity and efficiency while advancing PhilHealth’s RISE30 mission. Primary care has appropriately been identified as the backbone of reform.
The direction is sound. But Filipinos have seen many promising health plans launched with impressive presentations and strong declarations of partnership. The real test will not be the number of institutions endorsing the roadmap, but whether patients pay less, receive care earlier and encounter fewer obstacles.
Sixteen months is long enough to produce visible change—but short enough to demand discipline.
First, PhilHealth should translate the roadmap into a public implementation scorecard. Every major reform must have a named accountable official, a deadline, a budget, and measurable targets. At minimum, the dashboard should track claims-processing time, rejected and returned claims, actual benefit utilization, primary-care enrollment, provider payment delays, and patients’ out-of-pocket expenses. Results should be published quarterly and broken down by region, income group and type of health facility.
What is not measured is easily explained away.
Second, PhilHealth must make primary care real—not merely another entitlement that exists on paper. Every Filipino should be linked to an accessible primary-care provider that can deliver preventive services, essential diagnostics, maintenance medicines, and properly coordinated referrals. Particular attention must be given to geographically isolated communities, where automatic PhilHealth coverage means little if the nearest accredited clinic is several hours away.
PhilHealth should therefore set provincial targets for functional primary-care networks and use mobile clinics, telemedicine and public-private partnerships where government facilities remain inadequate.
Third, benefits must correspond more closely to the actual cost of care. Expanded packages are laudable, but their value is diminished when hospitals charge patients large remaining balances. Benefit rates should be reviewed regularly using credible cost data, with priority given to illnesses that most commonly impoverish Filipino families—cardiovascular disease, cancer, kidney disease, stroke, diabetes, serious infections, and complicated pregnancies.
The objective must be financial protection, not simply a higher reimbursement figure. The most meaningful question is: How much did the patient still have to pay?
Fourth, PhilHealth must accelerate payment reform. The planned transition toward diagnosis-related groups and prospective payment mechanisms can make reimbursement fairer and more responsive to the severity and complexity of illness. But implementation should begin with carefully evaluated pilot sites. Rates must be scientifically determined, quality safeguards established, and unintended consequences—such as premature discharge, undertreatment or avoidance of complicated patients—closely monitored.
Hospitals, meanwhile, deserve prompt payment of legitimate claims. Delayed reimbursement threatens their cash flow, disrupts services, and ultimately transfers the burden to patients.
Fifth, digitalization must simplify care rather than create a new bureaucracy. PhilHealth, the DOH, hospitals, laboratories, and local governments need interoperable information systems so that patients do not repeatedly submit the same documents. Claims should be tracked electronically, and members should be able to see the status of a claim, the amount paid by PhilHealth, and the lawful balance, if any, for which they are responsible.
Strong cybersecurity and protection of medical confidentiality must accompany this integration.
Sixth, anti-fraud measures should be intelligent and targeted. Data analytics can detect suspicious billing patterns without subjecting every honest physician and hospital to excessive paperwork. Fraud control and faster payment are not competing goals. A modern insurance system should be capable of doing both.
Finally, patients must have a seat at the table. Civil society participation should extend beyond ceremonial consultations. PhilHealth should establish an independent patient advisory council and a rapid grievance mechanism with enforceable response deadlines. Complaints about denied benefits, unauthorized charges and inaccessible services are not public-relations problems; they are evidence of where the system is failing.
RISE30 was conceived to rebuild trust, strengthen institutional capacity and create a faster, fairer and more reliable PhilHealth. Trust, however, cannot be proclaimed. It must be earned—one properly paid claim, one affordable hospitalization, and one protected Filipino family at a time.
The 16-month plan should therefore end not with another forum, but with a publicly audited accounting: what was promised, what was delivered, what remained unfinished, and how much patients actually saved.
For universal health care, the decisive metric is not the elegance of the roadmap. It is whether a sick Filipino can obtain timely, humane and competent care without being driven into debt. CS
Dr. Rafael R. Castillo is a cardiologist, educator, and public health advocate. He was president of the Philippine Heart Association (PHA) and the Asian Pacific Society of Hypertension, and was a longtime health columnist of the Inquirer. He has over 45 awards to his name, including the PHA Lifetime Achievement Award, and continues to champion preventive cardiology and public health reforms here and abroad.
